| MicardisPlus 40 mg/12.5 mg tablets EU/1/02/213/001-005 |
Telmisartan, Hydrochlorothiazide |
Boehringer Ingelheim International GmbH |
— |
| MicardisPlus 80 mg/12.5 mg tablets EU/1/02/213/006-010 |
Telmisartan, Hydrochlorothiazide |
Boehringer Ingelheim International GmbH |
— |
| MicardisPlus 80 mg/25 mg tablets EU/1/02/213/17-23 |
Telmisartan, Hydrochlorothiazide |
Boehringer Ingelheim International GmbH |
— |
| Micrazym 10000 units gastro-resistant capsules, hard PA22871/030/001 |
Pancreatin |
Azure Pharmaceuticals Ltd. |
Not marketed |
| Micrazym 25000 units gastro-resistant capsules, hard PA22871/030/002 |
Pancreatin |
Azure Pharmaceuticals Ltd. |
Not marketed |
| Midazolam Rowa 10 mg oromucosal solution PA0074/099/004 |
Midazolam |
Rowa Pharmaceuticals Limited, |
Marketed |
| Midazolam Rowa 2.5 mg oromucosal solution PA0074/099/001 |
Midazolam |
Rowa Pharmaceuticals Limited, |
Marketed |
| Midazolam Rowa 5 mg oromucosal solution PA0074/099/002 |
Midazolam |
Rowa Pharmaceuticals Limited, |
Marketed |
| Midazolam Rowa 7.5 mg oromucosal solution PA0074/099/003 |
Midazolam |
Rowa Pharmaceuticals Limited, |
Marketed |
| Midon 2.5 mg tablets PPA23080/024/001 |
Midodrine hydrochloride |
Merit Pharmaceuticals Limited |
— |
| Midon 5 mg tablets PPA23080/024/002 |
Midodrine hydrochloride |
Merit Pharmaceuticals Limited |
— |
| Miglustat Dipharma 100 mg hard capsules EU/1/18/1346/001 |
Miglustat |
Dipharma B.V. |
— |
| Miglustat Gen.Orph 100 mg hard capsules EU/1/17/1232/001-002 |
Miglustat |
Gen.Orph |
— |
| MINJUVI 200 mg powder for concentrate for solution for infusion EU/1/21/1570/001 |
Tafasitamab |
Incyte Biosciences Distribution B.V. |
— |
| MIRAPEXIN 0.088 mg tablets EU/1/97/051/001-002 |
Pramipexole dihydrochloride monohydrate |
Boehringer Ingelheim International GmbH |
— |
| MIRAPEXIN 0.18 mg tablets EU/1/97/051/003-004 |
Pramipexole dihydrochloride monohydrate |
Boehringer Ingelheim International GmbH |
— |
| MIRAPEXIN 0.26 mg prolonged-release tablets EU/1/97/051/13-15 |
Pramipexole dihydrochloride monohydrate |
Boehringer Ingelheim International GmbH |
— |
| MIRAPEXIN 0.35 mg tablets EU/1/97/051/011-012 |
Pramipexole dihydrochloride monohydrate |
Boehringer Ingelheim International GmbH |
— |
| MIRAPEXIN 0.52 mg prolonged-release tablets EU/1/97/051/16-18 |
Pramipexole dihydrochloride monohydrate |
Boehringer Ingelheim International GmbH |
— |
| MIRAPEXIN 0.7 mg tablets EU/1/97/051/005-006 |
Pramipexole dihydrochloride monohydrate |
Boehringer Ingelheim International GmbH |
— |
| MIRAPEXIN 1.05 mg prolonged-release tablets EU/1/97/051/19-21 |
Pramipexole dihydrochloride monohydrate |
Boehringer Ingelheim International GmbH |
— |
| MIRAPEXIN 1.57 mg prolonged-release tablets EU/1/97/051/028-30 |
Pramipexole dihydrochloride monohydrate |
Boehringer Ingelheim International GmbH |
— |
| MIRAPEXIN 2.1 mg prolonged-release tablets EU/1/97/051/22-24 |
Pramipexole dihydrochloride monohydrate |
Boehringer Ingelheim International GmbH |
— |
| MIRAPEXIN 2.62 mg prolonged-release tablets EU/1/97/051/031-33 |
Pramipexole dihydrochloride monohydrate |
Boehringer Ingelheim International GmbH |
— |
| MIRAPEXIN 3.15 mg prolonged-release tablets EU/1/97/051/25-27 |
Pramipexole dihydrochloride monohydrate |
Boehringer Ingelheim International GmbH |
— |
| Mircera 100 micrograms/0.3 ml solution for injection in pre-filled syringe EU/1/07/400/10 |
Methoxy peg-epoetin beta |
Roche Registration GmbH |
— |
| Mircera 120 micrograms/0.3 ml solution for injection in pre-filled syringe EU/1/07/400/20 |
Methoxy peg-epoetin beta |
Roche Registration GmbH |
— |
| Mircera 150 micrograms/0.3 ml solution for injection in pre-filled syringe EU/1/07/400/11 |
Methoxy peg-epoetin beta |
Roche Registration GmbH |
— |
| Mircera 200 micrograms/0.3 ml solution for injection in pre-filled syringe EU/1/07/400/12 |
Methoxy peg-epoetin beta |
Roche Registration GmbH |
— |
| Mircera 250 micrograms/0.3 ml solution for injection in pre-filled syringe EU/1/07/400/13 |
Methoxy peg-epoetin beta |
Roche Registration GmbH |
— |
| Mircera 30 micrograms/0.3 ml solution for injection in pre-filled syringe EU/1/07/400/17 |
Methoxy peg-epoetin beta |
Roche Registration GmbH |
— |
| Mircera 360 micrograms/0.6 ml solution for injection in pre-filled syringe EU/1/07/400/21 |
Methoxy peg-epoetin beta |
Roche Registration GmbH |
— |
| Mircera 50 micrograms/0.3 ml solution for injection in pre-filled syringe EU/1/07/400/008 |
Methoxy peg-epoetin beta |
Roche Registration GmbH |
— |
| Mircera 75 micrograms/0.3 ml solution for injection in pre-filled syringe EU/1/07/400/009 |
Methoxy peg-epoetin beta |
Roche Registration GmbH |
— |
| Mirtazapine Bluefish 15 mg film-coated tablets PA1436/045/001 |
Mirtazapine |
Bluefish Pharmaceuticals AB |
Not marketed |
| Mirtazapine Bluefish 15 mg orodispersible tablets PA1436/001/001 |
Mirtazapine |
Bluefish Pharmaceuticals AB |
Marketed |
| Mirtazapine Bluefish 30 mg film-coated tablets PA1436/045/002 |
Mirtazapine |
Bluefish Pharmaceuticals AB |
Not marketed |
| Mirtazapine Bluefish 30 mg orodispersible tablets PA1436/001/002 |
Mirtazapine |
Bluefish Pharmaceuticals AB |
Marketed |
| Mirtazapine Bluefish 45 mg film-coated tablets PA1436/045/003 |
Mirtazapine |
Bluefish Pharmaceuticals AB |
Not marketed |
| Mirtazapine Bluefish 45 mg orodispersible tablets PA1436/001/003 |
Mirtazapine |
Bluefish Pharmaceuticals AB |
Marketed |
| Mirvaso EU/1/13/904/001-003 |
Brimonidine |
Galderma International |
— |
| Mixtard EU/1/02/231/003-35,37 |
Insulin human, Insulin human |
Novo Nordisk A/S |
— |
| Mixtard EU/1/02/231/1-25 |
Insulin human |
Novo Nordisk A/S |
Not marketed |
| mNEXSPIKE dispersion for injection in pre-filled syringe COVID-19 mRNA Vaccine EU/1/25/2010/001-006 |
mRNA-1283 |
Moderna Biotech Spain S.L. |
— |
| Modafinil Bluefish 100 mg tablets PA1436/031/001 |
Modafinil |
Bluefish Pharmaceuticals AB |
Marketed |
| Modafinil Bluefish 200 mg tablets PA1436/031/002 |
Modafinil |
Bluefish Pharmaceuticals AB |
Marketed |
| Modigraf 0.2 mg granules for oral suspension EU/1/09/523/001 |
Tacrolimus |
Astellas Pharma Europe BV |
— |
| Modigraf 1 mg granules for oral suspension EU/1/09/523/002 |
Tacrolimus |
Astellas Pharma Europe BV |
— |
| Molipaxin 100 mg capsules PA23229/011/002 |
Trazodone hydrochloride |
Neuraxpharm Ireland Limited |
Marketed |
| Molipaxin 150mg Film-coated Tablets PA23229/011/003 |
Trazodone hydrochloride |
Neuraxpharm Ireland Limited |
Marketed |